ASH 2020: Novel CAR-T Approaches Chase BCMA-Targeting Frontrunners

New Poseida Manufacturing Boosts Efficacy; Allogene Has First Allogeneic

BMS/bluebird's ide-cel is in the lead but many CAR-T approaches follow • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Clinical Trials

More from R&D